He explained that the instrument observes the Sun's daily meridian altitude during north-south line crossing. In Delhi, the Sun never reaches precisely overhead due to the city's 5.1-degree latitude ...

Among them are the Massachusetts General Hospital, Boston Children’s Hospital, Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital and the Dana-Farber Cancer Institute.

Jitendra Singh, Union Minister of State for Science and Technology, officially launched indigenously developed HPV test kits for cervical cancer screening at a high-profile event in Delhi on Thursday.

This rare alignment can only be observed in places situated between the Equator and the Tropic of Cancer. Indian cities such as Bengaluru, Chennai, and Mangaluru fall within this geographical zone and ...

The Tropic of Cancer is not merely a geographical reference; it plays a pivotal role in climate and weather patterns. It represents the northernmost latitude at which the sun can appear directly ...

Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ultimately be used to develop new cancer drugs. Tempus will use its “vast ...

Experts developed consensus recommendations through the modified Delphi process for metastatic prostate cancer management during the 2024 US Prostate Cancer Conference. A multidisciplinary panel of ...

It happens twice a year in cities between the Equator and the Tropic of Cancer. Chennai and Mangaluru ... thus the sun does not travel in a straight line across the sky throughout the year.

Zero Shadow Day isn’t exclusive to Bengaluru-it occurs in all cities located between the Equator and the Tropic of Cancer, including Chennai and Mangaluru. In Bengaluru, this event typically takes ...

In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in first-line triple-negative breast cancer (TNBC), Gilead Sciences ...

AstraZeneca and Daiichi Sankyo are aiming to establish their star antibody-drug conjugate (ADC) Enhertu as a first-line treatment in HER2-positive breast cancer after recording “highly ...